Free Trial

Scilex (SCLXW) Competitors

Scilex logo
$0.05 -0.01 (-22.65%)
As of 04/17/2025 01:13 PM Eastern

SCLXW vs. ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, AONCW, AONC, WENAW, and APLMW

Should you be buying Scilex stock or one of its competitors? The main competitors of Scilex include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), American Oncology Network (AONCW), American Oncology Network (AONC), Anew Medical (WENAW), and Apollomics (APLMW). These companies are all part of the "medical" sector.

Scilex vs.

Scilex (NASDAQ:SCLXW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

In the previous week, Scilex had 3 more articles in the media than 180 Life Sciences. MarketBeat recorded 3 mentions for Scilex and 0 mentions for 180 Life Sciences. Scilex's average media sentiment score of 0.32 beat 180 Life Sciences' score of 0.00 indicating that Scilex is being referred to more favorably in the media.

Company Overall Sentiment
Scilex Neutral
180 Life Sciences Neutral

Scilex and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
ScilexN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scilex$56.59MN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
ScilexN/A N/A N/A
180 Life Sciences N/A N/A N/A

Summary

Scilex beats 180 Life Sciences on 3 of the 3 factors compared between the two stocks.

Get Scilex News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCLXW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SCLXW vs. The Competition

MetricScilexDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$89.90B$5.30B$7.35B
Dividend YieldN/A2.47%5.12%4.30%
P/E RatioN/A24.1121.8217.80
Price / SalesN/A154.60379.9697.74
Price / CashN/A17.5938.2634.64
Price / BookN/A2.856.443.98
Net IncomeN/A$3.43B$3.21B$247.73M
7 Day PerformanceN/A2.66%2.87%1.81%
1 Month PerformanceN/A-4.22%-8.64%-6.96%
1 Year PerformanceN/A-1.78%11.47%1.30%

Scilex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SCLXW
Scilex
N/A$0.05
-22.7%
N/A-78.1%$0.00$56.59M0.00105Gap Down
ATNFW
180 Life Sciences
N/A$0.01
-2.6%
N/A-20.2%$0.00N/A0.007Gap Down
SXTPW
60 Degrees Pharmaceuticals
N/A$0.05
-21.6%
N/A-50.2%$0.00$607,574.000.002
ACONW
Aclarion
N/A$0.05
-11.2%
N/A+97.0%$0.00$49,289.000.007
AIMDW
Ainos
N/A$0.08
-2.4%
N/A-2.0%$0.00$20,729.000.0040Gap Down
DRTSW
Alpha Tau Medical
N/A$0.22
+6.8%
N/A-6.3%$0.00N/A0.0080Gap Down
ALVOW
Alvotech
N/A$1.11
-14.6%
N/A-66.7%$0.00$489.68M0.004Gap Up
AONCW
American Oncology Network
N/A$0.26
flat
N/AN/A$0.00$1.34B0.001,525
AONC
American Oncology Network
N/A$5.60
+8.0%
N/A+32.7%$0.00$1.34B0.001,520Gap Up
WENAW
Anew Medical
N/A$0.04
-0.3%
N/AN/A$0.00N/A0.00N/AGap Down
APLMW
Apollomics
N/A$0.01
-22.8%
N/A-56.8%$0.00N/A0.0059Short Interest ↓
Positive News
High Trading Volume

Related Companies and Tools


This page (NASDAQ:SCLXW) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners